Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Supreme Court Case Could Have Impact On Device Suits, Lawyers Say

This article was originally published in The Gray Sheet

Executive Summary

If the Supreme Court favors "implied" federal pre-emption for FDA-approved pharmaceutical labeling in a case that will be heard by the court next month, some devices may receive additional protections too, lawyers suggest
Advertisement

Related Content

Supreme Court Hears Wyeth v. Levine Drug Pre-Emption Case
Supreme Court Hears Wyeth v. Levine Drug Pre-Emption Case
Division at FDA over preemption
Division at FDA over preemption
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
Democrats Seek To Overturn Supreme Court Device Liability Decision
SUPREME COURT MEDTRONIC V. LOHR RULING LEAVES POSSIBILITY OF TORT CLAIM PREEMPTION BY PMA REQUIREMENTS; PREEMPTION FOR 510(K) DEVICES ELIMINATED
Advertisement
UsernamePublicRestriction

Register

MT026681

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel